Usman Hassan1,2, Iftikhar Ali Rana3, Sajid Mushtaq3, Muhammad Azam3, Noreen Akhter3. 1. Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan. drusmanhassan256@gmail.com. 2. Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Johar Town, Lahore, Pakistan. drusmanhassan256@gmail.com. 3. Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
Abstract
INTRODUCTION: Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm, accounting for only 0.4% of soft-tissue sarcomas. It shows both nodal and extranodal involvement. Considering the rarity and difficulties in diagnosing this tumor, we consider it very important to share our experience of diagnosing FDCS. Its correct diagnosis cannot be overemphasized as the treatment and prognosis of FDCS are very much different from tumors which come in its differential diagnosis. MATERIAL AND METHODS: We are presenting eight cases of extranodal FDCS in gastrointestinal tract diagnosed at our center in a period of 3 years (Feb 2015 to Feb 2018). Presenting complaints, demographic details, gross description, histologic features, immunostain results, and clinical follow-up were evaluated. RESULTS: Four patients were females and four were males. Tumor ranged in size from 5.5 to 35 cm. In five cases, tumor cells were arranged in storiform and whorling pattern. Lymphocytes were seen sprinkled in between these cells. In one case, lymphocytic infiltrate was extensive. Giant cells and frequent mitoses were noted in two cases. One case showed extensive necrosis. Tumor cells were strongly and diffusely positive for CD21 and CD35. Mean follow up of 11.8 months (range 01 to 24 months) was noted. CONCLUSION: FDCS is a rare tumor having distinct morphology and phenotype which if known can be correctly diagnosed. Therefore, knowledge of its varied location, morphology, and phenotype is very important to correctly diagnose this tumor and to prevent misdiagnosis and mistreatment.
INTRODUCTION:Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm, accounting for only 0.4% of soft-tissue sarcomas. It shows both nodal and extranodal involvement. Considering the rarity and difficulties in diagnosing this tumor, we consider it very important to share our experience of diagnosing FDCS. Its correct diagnosis cannot be overemphasized as the treatment and prognosis of FDCS are very much different from tumors which come in its differential diagnosis. MATERIAL AND METHODS: We are presenting eight cases of extranodal FDCS in gastrointestinal tract diagnosed at our center in a period of 3 years (Feb 2015 to Feb 2018). Presenting complaints, demographic details, gross description, histologic features, immunostain results, and clinical follow-up were evaluated. RESULTS: Four patients were females and four were males. Tumor ranged in size from 5.5 to 35 cm. In five cases, tumor cells were arranged in storiform and whorling pattern. Lymphocytes were seen sprinkled in between these cells. In one case, lymphocytic infiltrate was extensive. Giant cells and frequent mitoses were noted in two cases. One case showed extensive necrosis. Tumor cells were strongly and diffusely positive for CD21 and CD35. Mean follow up of 11.8 months (range 01 to 24 months) was noted. CONCLUSION: FDCS is a rare tumor having distinct morphology and phenotype which if known can be correctly diagnosed. Therefore, knowledge of its varied location, morphology, and phenotype is very important to correctly diagnose this tumor and to prevent misdiagnosis and mistreatment.
Authors: Mrinal Gounder; Ved Desai; Deborah Kuk; Narasimhan Agaram; Maria Arcila; Benjamin Durham; Mary L Keohan; Mark A Dickson; Sandra P D'Angelo; Neerav Shukla; Craig Moskowitz; Ariela Noy; Robert G Maki; Diego Adrianzen Herrera; Armando Sanchez; Anita Krishnan; Andrew Pourmoussa; Li-Xuan Qin; William D Tap Journal: Eur J Cancer Date: 2015-08-19 Impact factor: 9.162
Authors: Rosario Granados; José Antonio Aramburu; José María Rodríguez; María Antonia Nieto Journal: Diagn Cytopathol Date: 2008-01 Impact factor: 1.582
Authors: Stefan Martin Kröber; Alexander Marx; Hermann Aebert; Bernhard M Dohmen; Edwin Kaiserling Journal: Hum Pathol Date: 2004-02 Impact factor: 3.466
Authors: Ebru Cakir; N Engin Aydin; Emine Samdanci; Nese Karadag; Sadegul Sayin; Ahmet Kizilay Journal: J Pak Med Assoc Date: 2013-03 Impact factor: 0.781